Michael J. Hadd,Michael D. Hocker,Mark W. Holladay,Gang Liu,Martin W. Rowbottom,Shimin Xu
申请号：
US13651312
公开号：
US20130096113A1
申请日:
2012.10.12
申请国别(地区):
US
年份:
2013
代理人:
摘要：
Provided herein are heterocyclic compounds for treatment of CSF1R, FLT3, KIT, and/or PDGFRβ kinase mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.
